ROR1 and cancer: With the growth of the ID8 cell-transplantable EOC being suppressed, the cytotoxic activities of splenocytes, NK cells, and CDC as well as serum anti ROR-1 antibody and IFN-γ levels were increased in the ID8 cancer stem-like cell-vaccinated mice, suggesting elicit effective immunity against EOC.